ifosfamide has been researched along with Hemangioendothelioma in 1 studies
Hemangioendothelioma: A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharif, K | 1 |
| English, M | 1 |
| Ramani, P | 1 |
| Alberti, D | 1 |
| Otte, JB | 1 |
| McKiernan, P | 1 |
| Gosseye, S | 1 |
| Jenney, M | 1 |
| de Ville de Goyet, J | 1 |
1 other study available for ifosfamide and Hemangioendothelioma
| Article | Year |
|---|---|
Management of hepatic epithelioid haemangio-endothelioma in children: what option?
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 2004 |